Publication Name	World Journal of Stem Cells
Manuscript ID	23217
Country	Australia

Received	2015-10-30 17:27
Peer-Review Started	2015-11-04 09:39
To Make the First Decision	2015-11-24 14:55
Return for Revision	2015-11-30 16:34
Revised	2015-12-23 15:27
Second Decision	2016-01-25 14:49
Accepted by Journal Editor-in-Chief	2016-01-25 18:07
Accepted by Executive Editor-in-Chief	2016-02-16 09:58
Articles in Press	2016-02-16 09:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-04-27 17:07
Publish the Manuscript Online	2016-05-18 08:39

ISSN	1948-0210 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Review
Article Title	Endometrial mesenchymal stem cells as a cell based therapy for pelvic organ prolapse
Manuscript Source	Invited Manuscript
All Author List	Stuart J Emmerson and Caroline E Gargett
Funding Agency and Grant Number
Corresponding Author	Caroline E Gargett, PhD, Associate Professor, the Ritchie Centre, Hudson Institute of Medical Research, 27-31 Wright Street, Melbourne, Victoria 3168, Australia. caroline.gargett@hudson.org.au
Key Words	Endometrium; Mesenchymal stem cells; Endometrial mesenchymal stem cells; Pelvic organ prolapse; Mesh; Tissue engineering; Regenerative medicine
Core Tip	Pelvic organ prolapse is the herniation of pelvic organs into the vaginal cavity and affects approximately 25% of all women. Traditional mesh-augmented surgical treatments cause complications such as pain and mesh erosion. A tissue engineering approach using endometrial mesenchymal stem cells seeded on new composite mesh show promise in animal models through their modulation of the chronic inflammatory response and promotion of physiological and biomechanically compliant neotissue.
Publish Date	2016-05-18 08:39
Citation	Emmerson SJ, Gargett CE. Endometrial mesenchymal stem cells as a cell based therapy for pelvic organ prolapse. World J Stem Cells 2016; 8(5): 202-215
URL	http://www.wjgnet.com/1948-0210/full/v8/i5/202.htm
DOI	http://dx.doi.org/10.4252/wjsc.v8.i5.202

Full Article (PDF)	WJSC-8-202.pdf
Full Article (Word)	WJSC-8-202.doc
Manuscript File	23217-Review.docx
Answering Reviewers	23217-Answering reviewers.pdf
Audio Core Tip	23217-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	23217-Conflict-of-interest statement.pdf
Copyright License Agreement	23217-Copyright assignment.pdf
Peer-review Report	23217-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	23217-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	23217-Scientific misconduct check.pdf
Scientific Editor Work List	23217-Scientific editor work list.pdf